Viral gene delivery selectively restores feeding and prevents lethality of dopamine-deficient mice

Neuron

Volumn 22, Issue 1, 1999, Pages 167-178

  Szczypka, Mark S ^a   Mandel, Ronald J ^b,c   Donahue, Brian A ^b   Snyder, Richard O ^b   Leff, Stuart E ^b   Palmiter, Richard D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b CELL GENESYS INC   (United States)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APHAGIA; ARTICLE; CONTROLLED STUDY; COORDINATION; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ENZYME DEFICIENCY; FEEDING BEHAVIOR; GENE TARGETING; LETHALITY; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS RECOMBINANT;

EID: 0032909651     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80688-1     Document Type: Article

References (55)

1. Accili, D., Fishburn, C.S., Drago, J., Steiner, H., Lachowicz, J.E., Park, B.H., Gauda, E.B., Lee, E.J., Cool, M.H., Sibley, D.R. et al. (1996). A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. USA 93, 1945-1949.
2. Aubert, A., Goodall, G., Dantzer, R., and Gheusi, G. (1997). Differential effects of lipopolysaccharide on pup retrieving and nest building in lactating mice. Brain Behav. Immun. 11, 107-118.
3. Anand, B.K., and Brobeck, J.R. (1951). Hypothalamic control of food intake in rats and cats. Yale J. Biol. Med. 24, 123-140.
4. Baik, J.H., Picetti, R., Saiardi, A., Thiriet, G., Dierich, A., Depaulis, A., Le-Meur, M., and Borrelli, E. (1995). Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377, 424-428.
5. Dahlstrom, A., and Fuxe, K. (1964). Localization of monoamines in the lower brain stem. Experientia 20, 398-399.
6. Davidson, B.L., Allen, E.D., Kozarsky, K.F., Wilson, J.M., and Roessler, B.J. (1993). A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat. Genet. 3, 219-223.
7. Drago, J., Gerfen, C.R., Lachowicz, J.E., Steiner, H., Hollon, T.R., Love, P.E., Ooi, G.T., Grinberg, A., Lee, E.J., Huang, S.P. et al. (1994). Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc. Natl. Acad. Sci. USA 91, 12564-12568.
8. During, M.J., Naegele, J.R., O'Malley, K.L., and Geller, A. (1994). Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266, 1399-1403.
9. Fernandez-Ruiz, J., Miranda, M.I., Bermudez-Rattoni, F., and Drucker-Colin, R. (1993). Effects of catecholaminergic depletion of the amygdala and insular cortex on the potentiation of odor by taste aversions. Behav. Neural. Biol. 3, 189-191.
10. Fibiger, H.C., Zis, A.P., and McGeer, E.G. (1973). Feeding and drinking deficits after 6-hydroxydopamine administration in the rat: Similarities to the lateral hypothalamic syndrome. Brain Res. 1,135-148.
11. Franklin, K.B.J., and Paxinos, G. (1997). The Mouse Brain in Stereotaxic Coordinates (New York: Academic Press).
12. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M., and Caron, M.G. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
13. Hajnal, A., and Lenard, L. (1997). Feeding-related dopamine in the amygdala of freely moving rats. Neuroreport 8, 2817-2820.
14. Heffner, T.G., Hartman, J.A., and Seiden, L.S. (1980). Feeding increases dopamine metabolism in the rat brain. Science 208, 1168-1170.
15. Hoebel, B.G., Hernandez, L., Schwartz, D.H., Mark, G.P., and Hunter, G.A. (1989). Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications. Ann. N.Y. Acad. Sci. 575, 171-191.
16. Hoebel, B.G., Mark, G.P., and West, H.L. (1992). Conditioned release of neurotransmitters as measured by microdialysis. Clin. Neuropharmacol. 15 (Suppl. 1), 704A-705A.
17. Horellou, P., Vigne, E., Castel, M.N., Barnéoud, P., Colin, P., Perricaudet, M., Delaere, P., and Mallet, J. (1994). Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. Neuroreport. 6, 49-53.
18. Hornykiewicz, O. (1966). Dopamine (3-hydroxytyramine) and brain function. Pharmacol. Rev. 18, 925-964.
19. Hurd, Y.L., Weiss, F., Koob, G.F., And, N.E., and Ungerstedt, U. (1989). Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: An in vivo microdialysis study. Brain Res. 498, 199-203.
20. Kaplitt, M.G., Leone, P., Samulski, R.J., Xiao, X., Pfaff, D.W., O'Malley, K.L., and During, M.J. (1994). Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8, 148-154.
21. Kessler, P.D., Podsakoff, G.M., Chen, X., McQuiston, S.A., Colosi, P.C., Matelis, L.A., Kurtzman, G.J., and Byrne, B.J. (1996). Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93, 14082-14087.
22. Koob, G.F. (1992). Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13, 81-96.
23. Koob, G.F., and Nestler, E.J. (1997). The neurobiology of drug addiction. J. Neuropsych. Clin. Neurosci. 9, 482-497.
24. Kopin, I.J., and Markey, S.P. (1988). MPTP toxicity: Implications for research in Parkinson's disease. Annu. Rev. Neurosci. 11, 81-96.
25. Langston, J.W., Irwin, L, Langston, E.B., and Forno, L.S. (1984). 1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci. Lett. 48, 87-92.
26. Leibowitz, S.F., and Brown, L.L. (1980). Histochemical and pharmacological analysis of catecholaminergic projections to the perifornical hypothalamus in relation to feeding inhibition. Brain Res. 2, 315-345.
27. Lentz, S.I., and Kapatos, G. (1996). Tetrahydrobiopterin biosynthesis in the rat brain: Heterogeneity of GTP cyclohydrolase I mRNA expression in monoamine-containing neurons. Neurochem. Int. 28, 569-582.
28. Levine, R.A., Kapatos, G., Kaufman, S., and Milstein, S. (1990). Immunological evidence for the requirement of sepiapterin reductase for tetrahydrobioptern biosynthesis in brain. J. Neurochem. 54, 1218-1224.
29. Li, J., Samulski, R.J., and Xiao, X. (1997). Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol. 71, 5236-5243.
30. Lindvall, O., and Bjorklund A. (1983). Dopamine and norepinephrine-containing neuron systems: Their anatomy in the rat brain. In ChemiCal Neuroanatomy, P.C. Emson, ed. (New York: Raven Press), pp. 229-255.
31. Maldonado, R., Saiardi, A., Valverde, O., Samad, T.A., Roques, B.P., and Borrelli, E. (1997). Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388, 586-589.
32. Maldonado-Irizarry, C.A., Swanson, C.J., and Kelley, A.E. (1995). Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. J. Neurosci. 15, 6770-6788.
33. Mandel, R.J., Rendahl, K.G., Spratt, S.K., Snyder, R.O., Cohen, L.K., and Leff, S.E. (1998). Characterization of intrastriatal recombinant adeno-associated virus mediated gene transfer of human tyrosine hydroxyalse and human GTP cyclohydrolase I in a rat model of Parkinson's disease. J. Neurosci. 18, 4271-4284.
34. Martel, P., and Fantino, M. (1996a). Influence of the amount of food ingested on mesolimbic dopaminergic system activity: A microdialysis study. Pharmacol. Biochem. Behav. 55, 297-302.
35. Martel, P., and Fantino, M. (1996b). Mesolimbic dopaminergic system activity as a function of food reward: A microdialysis study. Pharmacol. Biochem. Behav. 53, 221-226.
36. Miao, C.H., Snyder, R.O., Schowalter, D.B., Patjin, G.A., Donahue, B.A., Winther, B., and Kay, M.A. (1998). The kinetics of rAAV integration in the liver. Nat. Genet. 19, 13-15.
37. Mogenson, G.J., and Wu, M. (1982). Electrophysiological and behavioral evidence of interaction of dopaminergic and gustatory afferents in the amygdala. Brain Res. Bull. 8, 685-691.
38. Nichol, C.A., Smith, G.K., and Duch, D.S. (1985). Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. Annu. Rev. Biochem. 54, 729-764.
39. Ogawa, N., Hirose, Y., Ohara, S., Ono, T., and Watanabe, Y. (1985) A simple quantitative bradykinesia test in MPTP-treated mice. Res. Commun. Chem. Pathol. Pharmacol. 50, 435-441.
40. Pontieri, F.E., Tanda, G., and Di Chiara, G. (1995). Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A. 92, 12304-12308.
41. Rubinstein, M., Phillips, T.J., Bunzow, J.R., Falzone, T.L., Dziewczapolski, G., Zhang, G., Fang, Y., Larson, J.L., McDougalll, J.A., Chester, J.A. et al. (1997). Mice lacking dopamine D4 receptors are super-sensitive to ethanol, cocaine, and methamphetamine. Cell 90, 991-1001.
42. Salamone, J.D., Zigmond, M.J., and Stricker, E.M. (1990). Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions. Neuroscience 39, 17-24.
43. Self, D.W., and Nestler, E.J. (1995). Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18, 463-495.
44. Sherwin, C.M. (1997). Observations on the prevalence of nest-building in non-breeding TO strain mice and their use of two nesting materials. Lab. Anim. 31, 125-132.
45. Slotnick, B.M., and Leonard, C.A. (1975). A Stereotaxic Atlas of The Albino Mouse Forebrain. (Bethesda, MD: Department of Health, Education, and Welfare, NIH; U.S. Government).
46. Swanson, C.J., Heath, S., Stratford, T.R., and Kelley, A.E. (1997). Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmacol. Biochem. Behav. 58, 933-945.
47. Taber, M.T., and Fibiger, H.C. (1997). Feeding-evoked dopamine release in the nucleus, accumbens: Regulation by glutamatergic mechanisms. Neuroscience 76, 1105-1112.
48. Ungerstedt, U. (1971). Adipsia and aphagia after 6-hydoxydopamine induced degeneration of the nigrostriatal dopamine system. Acta Physiol. Scand. (Suppl.) 367, 49-122.
49. Wilson, C., Nomikos, G.G., Collu, M., and Fibiger, H.C. (1995). Dopaminergic correlates of motivated behavior: Importance of drive. J. Neurosci. 15, 5169-5178.
50. Winn, P., Williams, S.F., and Herberg, L.J. (1982). Feeding stimulated by very low doses of d-amphetamine administered systemically or by microinjection into the striatum. Psychopharm. Berl. 78,336-341.
51. Wise, R.A., and Hoffman, D.C. (1992). Localization of drug reward mechanism by intracranial injections. Synapse 10, 247-263
52. Xu, M., Moratalla, R., Gold, L.H., Hiroi, N., Koob, G.F., Graybiel, A.M., and Tonegawa, S. (1994). Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79, 729-742.
53. Xu, M., Koeltzow, T.E., Santiago, G.T., Moratalla, R., Cooper, D.C., Hu, X.T., White, N.M., Graybiel, A.M., White, F.J., and Tonegawa, S. (1997). Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 19, 837-848.
54. Yang, Z.J., Meguid, M.M., Chai, J.K., Chen, C., and Oler, A. (1997). Bilateral hypothalamic dopamine infusion in male zucker rat suppresses feeding due to reduced meal size. Pharmacol. Biochem. Behav. 3, 631-635.
55. Zhou, Q.Y., and Palmiter, R.D. (1995). Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83, 1197-1209.